Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

14.1K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.3K
Protein Networks02:26

Protein Networks

4.2K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.4K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.4K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.5K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.5K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

8.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GraphLooper: predicting chromatin loops based on hierarchical multi-view graph pooling method.

Briefings in bioinformatics·2026
Same author

Multi-species integration, alignment and annotation of single-cell RNA-seq data with CAMEX.

Nature communications·2026
Same author

Biolinguistic graph fusion model for circRNA-miRNA association prediction.

Briefings in bioinformatics·2024
Same author

Likelihood-based feature representation learning combined with neighborhood information for predicting circRNA-miRNA associations.

Briefings in bioinformatics·2024
Same author

iGRLDTI: an improved graph representation learning method for predicting drug-target interactions over heterogeneous biological information network.

Bioinformatics (Oxford, England)·2023
Same author

A geometric deep learning framework for drug repositioning over heterogeneous information networks.

Briefings in bioinformatics·2022

Related Experiment Video

Updated: Nov 7, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K

A Novel Method to Predict Drug-Target Interactions Based on Large-Scale Graph Representation Learning.

Bo-Wei Zhao1,2,3, Zhu-Hong You1,2,3, Lun Hu1,2,3

  • 1The Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Sciences, Urumqi 830011, China.

Cancers
|April 30, 2021
PubMed
Summary
This summary is machine-generated.

We developed LGDTI, a novel graph representation learning method for predicting drug-target interactions (DTIs). This computational approach efficiently identifies potential DTIs, accelerating drug discovery and repositioning.

Keywords:
computational methoddrug discoverydrug-target interactionslarge-scale graph representation learning

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.4K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

604

Related Experiment Videos

Last Updated: Nov 7, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.4K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

604

Area of Science:

  • Computational biology
  • Bioinformatics
  • Drug discovery

Background:

  • Identifying drug-target interactions (DTIs) is crucial for drug discovery and repositioning.
  • Traditional experimental methods for DTI identification are time-consuming and labor-intensive.
  • Computational models offer a faster alternative for predicting high-quality DTI candidates.

Purpose of the Study:

  • To propose a novel computational method, LGDTI, for predicting DTIs.
  • To leverage large-scale graph representation learning for enhanced DTI prediction.
  • To capture both local and global structural information within biological networks.

Main Methods:

  • LGDTI integrates Graph Convolutional Networks (GCN) to aggregate first-order neighbor information.
  • DeepWalk, a graph embedding method, is employed to learn high-order neighbor information.
  • Features from GCN and DeepWalk are combined and fed into a Random Forest classifier for DTI prediction.

Main Results:

  • LGDTI achieved an Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.9455.
  • The method obtained an Area Under the Precision-Recall Curve (AUPR) of 0.9491.
  • Performance was validated using 5-fold cross-validation and comparison with state-of-the-art methods.

Conclusions:

  • LGDTI demonstrates efficient and robust prediction of undiscovered DTIs.
  • The model offers a promising computational approach for accelerating drug discovery.
  • The proposed method provides novel perspectives for researchers in the field.